Glucose-6-phosphate Dehydrogenase Deficiency and Long-term Risk of Immune-related Disorders

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Sep 27

PMID 37753082

Authors

Ariel Israel

Alejandro A Schaffer

Matitiahu Berkovitch

David J Ozeri

Eugene Merzon

Ilan Green

Avivit Golan-Cohen

Eytan Ruppin

Shlomo Vinker

Eli Magen

Affiliations

Soon will be listed here.

Abstract

Introduction: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked enzymatic disorder that is particularly prevalent in Africa, Asia, and the Middle East. This study aimed to assess the long-term health risks associated with G6PD deficiency.

Methods: A retrospective cohort study was conducted using data from a national healthcare provider in Israel (Leumit Health Services). A total of 7,473 G6PD-deficient individuals were matched with 29,892 control subjects in a 1:4 ratio, based on age, gender, socioeconomic status, and ethnic groups. The exposure of interest was recorded G6PD diagnosis or positive G6PD diagnostic test. The main outcomes and measures included rates of infectious diseases, allergic conditions, and autoimmune disorders between 2002 and 2022.

Results: Significantly increased rates were observed for autoimmune disorders, infectious diseases, and allergic conditions in G6PD-deficient individuals compared to the control group. Specifically, notable increases were observed for rheumatoid arthritis (odds ratio [OR] 2.41, p<0.001), systemic lupus erythematosus (OR 4.56, p<0.001), scleroderma (OR 6.87, p<0.001), pernicious anemia (OR 18.70, p<0.001), fibromyalgia (OR 1.98, p<0.001), Graves' disease (OR 1.46, p=0.001), and Hashimoto's thyroiditis (OR 1.26, p=0.001). These findings were supported by elevated rates of positive autoimmune serology and higher utilization of medications commonly used to treat autoimmune conditions in the G6PD-deficient group.

Discussion: In conclusion, individuals with G6PD deficiency are at a higher risk of developing autoimmune disorders, infectious diseases, and allergic conditions. This large-scale observational study provides valuable insights into the comprehensive association between G6PD deficiency and infectious and immune-related diseases. The findings emphasize the importance of considering G6PD deficiency as a potential risk factor in clinical practice and further research is warranted to better understand the underlying mechanisms of these associations.

Citing Articles

Increased exercise tolerance in humanized G6PD-deficient mice.

Cendali F, Lisk C, Dzieciatkowska M, LaCroix I, Reisz J, Harral J Blood Adv. 2024; 9(2):321-334.

PMID: 39514761 PMC: 11786683. DOI: 10.1182/bloodadvances.2024013968.

Lupus and other autoimmune diseases: Epidemiology in the population of African ancestry and diagnostic and management challenges in Africa.

Essouma M, Noubiap J J Allergy Clin Immunol Glob. 2024; 3(4):100288.

PMID: 39282618 PMC: 11399606. DOI: 10.1016/j.jacig.2024.100288.

Mitochondrial Plasticity and Glucose Metabolic Alterations in Human Cancer under Oxidative Stress-From Viewpoints of Chronic Inflammation and Neutrophil Extracellular Traps (NETs).

Lee H, Lin C, Liu C, Chen P, Tsai C, Wei Y Int J Mol Sci. 2024; 25(17).

PMID: 39273403 PMC: 11395599. DOI: 10.3390/ijms25179458.

Association of Rheumatoid Arthritis with Glucose-6-Phosphate Dehydrogenase Deficiency: Results from a Case-Control Study.

Dore M, Pes G, Mereu S, Piroddu J, Cavagna L, Erre G Mediterr J Hematol Infect Dis. 2024; 16(1):e2024056.

PMID: 38984095 PMC: 11232680. DOI: 10.4084/MJHID.2024.056.

The global role of G6PD in infection and immunity.

Shah S, Stone E, Francis R, Karafin M Front Immunol. 2024; 15:1393213.

PMID: 38938571 PMC: 11208698. DOI: 10.3389/fimmu.2024.1393213.

References

Cocco P, Todde P, Fornera S, Manca M, Manca P, Sias A . Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency. Blood. 1998; 91(2):706-9. View

Rostami-Far Z, Ghadiri K, Rostami-Far M, Shaveisi-Zadeh F, Amiri A, Rahimian Zarif B . Glucose-6-phosphate dehydrogenase deficiency (G6PD) as a risk factor of male neonatal sepsis. J Med Life. 2016; 9(1):34-38. PMC: 5152609. View

Yang H, Cheng M, Ho H, Chiu D . The microbicidal and cytoregulatory roles of NADPH oxidases. Microbes Infect. 2010; 13(2):109-20. DOI: 10.1016/j.micinf.2010.10.008. View

Piera-Velazquez S, Jimenez S . Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases. Physiol Rev. 2019; 99(2):1281-1324. PMC: 6734087. DOI: 10.1152/physrev.00021.2018. View

Lee T, Kim S, Yu S, Kim S, Park D, Moon H . Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood. 2003; 101(12):5033-8. DOI: 10.1182/blood-2002-08-2548. View

Wang H, Liu M . Complement C4, Infections, and Autoimmune Diseases. Front Immunol. 2021; 12:694928. PMC: 8317844. DOI: 10.3389/fimmu.2021.694928. View

Prado C, Martins M, Tiberio I . Nitric oxide in asthma physiopathology. ISRN Allergy. 2013; 2011:832560. PMC: 3658695. DOI: 10.5402/2011/832560. View

Israel A, Merzon E, Schaffer A, Shenhar Y, Green I, Golan-Cohen A . Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study. BMJ. 2021; 375:e067873. PMC: 9083235. DOI: 10.1136/bmj-2021-067873. View

Scofield R, Kurien B, Ganick S, McClain M, Pye Q, James J . Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic Biol Med. 2005; 38(6):719-28. DOI: 10.1016/j.freeradbiomed.2004.11.001. View

10.

Pes G, Errigo A, Soro S, Longo N, Dore M . Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin. Acta Oncol. 2019; 58(9):1205-1211. DOI: 10.1080/0284186X.2019.1616815. View

11.

van Bruggen R, Bautista J, Petropoulou T, de Boer M, van Zwieten R, Gomez-Gallego F . Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood. 2002; 100(3):1026-30. DOI: 10.1182/blood.v100.3.1026. View

12.

Beutler E . G6PD deficiency. Blood. 1994; 84(11):3613-36. View

13.

Mondal A, Mukherjee S, Dar W, Upadhyay P, Ranganathan A, Pati S . G6PD deficiency: imbalance of functional dichotomy contributing to the severity of COVID-19. Future Microbiol. 2022; 17:1161-1170. PMC: 9332910. DOI: 10.2217/fmb-2021-0299. View

14.

Ruwende C, Khoo S, Snow R, Yates S, Kwiatkowski D, Gupta S . Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 1995; 376(6537):246-9. DOI: 10.1038/376246a0. View

15.

Nkhoma E, Poole C, Vannappagari V, Hall S, Beutler E . The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009; 42(3):267-78. DOI: 10.1016/j.bcmd.2008.12.005. View

16.

Ferraris A, Broccia G, Meloni T, Forteleoni G, Gaetani G . Glucose 6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy. Am J Hum Genet. 1988; 42(3):516-20. PMC: 1715161. View

17.

Tishkoff S, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G . Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science. 2001; 293(5529):455-62. DOI: 10.1126/science.1061573. View

18.

Israel A, Berkovitch M, Merzon E, Golan-Cohen A, Green I, Ruppin E . Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019. Clin Infect Dis. 2023; 77(7):972-975. PMC: 10552581. DOI: 10.1093/cid/ciad348. View

19.

Yang H, Cheng M, Hua Y, Wu Y, Lin H, Liu H . Glucose 6-phosphate dehydrogenase knockdown enhances IL-8 expression in HepG2 cells via oxidative stress and NF-κB signaling pathway. J Inflamm (Lond). 2015; 12:34. PMC: 4419400. DOI: 10.1186/s12950-015-0078-z. View

20.

Hsieh Y, Lin M, Ho H, Chen L, Chen C, Shu J . Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus. PLoS One. 2013; 8(11):e79566. PMC: 3817128. DOI: 10.1371/journal.pone.0079566. View